Prognostic role of the neutrophil-to-lymphocyte ratio in patients with chronic kidney disease
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The neutrophil-to-lymphocyte ratio (NLR) has a prognostic value in cardiovascular disease, infection, inflammatory disease, and several malignancies. Therefore, the NLR has a possible predictive value in patients with chronic kidney disease (CKD), but this predictive value has not been validated. Here, we aimed to investigate the possibility of NLR as a predictor of CKD progression. Methods: This retrospective observational study included 141 patients with non-dialysis CKD. The participants were divided into terciles (T1, T2, and T3) according to NLR. The primary outcome was defined as a composite kidney event, which included a decline in the estimated glomerular filtration rate (eGFR) of at least 50% or initiation of renal replacement therapy during the follow-up period. Results: The mean follow-up duration was 5.45 ± 2.11 years. The mean NLRs were 1.35 ± 0.05 in T1 (n = 47), 2.16 ± 0.04 in T2 (n = 47), and 4.29 ± 0.73 in T3 (n = 47). The group with the highest NLR (T3) had higher baseline CKD and serum creatinine and lower eGFR levels than the group with the lowest NLR (T1). The cumulative incidence rate of composite kidney events was significantly higher in T3 compared with T1 (p < 0.001, log-rank test). Cox regression analysis revealed that high NLR was associated with the risk of composite kidney events (adjusted hazard ratio, 3.33; 95% confidence interval, 1.43–7.76). Conclusions: A higher NLR reflects the more advanced stage of CKD and suggests a role for NLR as a biomarker for predicting CKD progression.
Abstract
Background/Aims: The neutrophil-to-lymphocyte ratio (NLR) has a prognostic value in cardiovascular disease, infection, inflammatory disease, and several malignancies. Therefore, the NLR has a possible predictive value in patients with chronic kidney disease (CKD), but this predictive value has not been validated. Here, we aimed to investigate the possibility of NLR as a predictor of CKD progression. Methods: This retrospective observational study included 141 patients with non-dialysis CKD. The participants were divided into terciles (T1, T2, and T3) according to NLR. The primary outcome was defined as a composite kidney event, which included a decline in the estimated glomerular filtration rate (eGFR) of at least 50% or initiation of renal replacement therapy during the follow-up period. Results: The mean follow-up duration was 5.45 ± 2.11 years. The mean NLRs were 1.35 ± 0.05 in T1 (n = 47), 2.16 ± 0.04 in T2 (n = 47), and 4.29 ± 0.73 in T3 (n = 47). The group with the highest NLR (T3) had higher baseline CKD and serum creatinine and lower eGFR levels than the group with the lowest NLR (T1). The cumulative incidence rate of composite kidney events was significantly higher in T3 compared with T1 (p < 0.001, log-rank test). Cox regression analysis revealed that high NLR was associated with the risk of composite kidney events (adjusted hazard ratio, 3.33; 95% confidence interval, 1.43–7.76). Conclusions: A higher NLR reflects the more advanced stage of CKD and suggests a role for NLR as a biomarker for predicting CKD progression.
참고문헌 (17)
- Manabe I, "Chronic inflammation links cardiovascular, metabolic and renal diseases", Circ J, 75, pp.2739~2748 (2011)
- Turkmen K, "The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients", Ren Fail, 34, pp.155~159 (2012)
- Navarro JF, "Renal pro-inflammatory cytokine gene expression in diabetic nephropathy : effect of angiotensin-converting enzyme inhibition and pentoxifylline administration", Am J Nephrol, 26, pp.562~570 (2006)
- Fogo AB, "Mechanisms of progression of chronic kidney disease", Pediatr Nephrol, 22, pp.2011~2022 (2007)
- Tamhane UU, "Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome", Am J Cardiol, 102, pp.653~657 (2008)
- Wang X, "Prognostic value of neutrophil to lymphocyte ratio in heart failure patients", Clin Chim Acta, 485, pp.44~49 (2018)
- Walsh SR, "Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer", J Surg Oncol, 91, pp.181~184 (2005)
- Zucker A, "Prognostic role of baseline neutrophil-to-lymphocyte ratio in metastatic solid tumors", Mol Clin Oncol, 13, pp.25~ (2020)
- Altunoren O, "Does neutrophyl to lymphocyte ratio really predict chronic kidney disease progression?", Int Urol Nephrol, 51, pp.129~137 (2019)
- 10 Yoshitomi R, "High neutrophil", lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease, 2019, pp.41, 238~243
- Kocyigit I, "Role of neutrophil", lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease, 2013, pp.26, 358~365
- Okyay GU, "Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease", Ren Fail, 35, pp.29~36 (2013)
- Stevens LA, "Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities", Kidney Int, 79, pp.555~562 (2011)
- Charlson M, "Validation of a combined comorbidity index", J Clin Epidemiol, 47, pp.1245~1251 (1994)
- Kidney Disease : Improving Global Outcomes(KDIGO)Diabetes Work Group, "KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease", Kidney Int, 102(5S), pp.S1~S127 (2022)
- An X, "Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patients", Int Urol Nephrol, 44, pp.1521~1528 (2012)
- Tatar E, "The association of neutrophil", lymphocyte ratio and platelet, Acta Clin Belg, pp.2016, 71[DOI]